Reuters logo
BRIEF-American Regent announces enrollment of first patient in phase 3 trial
April 24, 2017 / 11:19 AM / 8 months ago

BRIEF-American Regent announces enrollment of first patient in phase 3 trial

April 24 (Reuters) - American Regent:

* American Regent announces enrollment of first patient in phase 3 trial to investigate injectafer (ferric carboxymaltose) as treatment for heart failure with iron deficiency Source text for Eikon:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below